Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M

May.08.2025
Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M
Smoore International has granted a total of 4.004 million shares to 49 employees under its share award and option plans. The package includes 1.614 million awarded shares and 2.39 million options exercisable at HK$13.52 per share, with a total value of HK$54.14 million.

On May 7, 2025, Smoore International Holdings Limited (HKEX: 6969) issued two announcements, declaring that it has granted stock awards and stock options to multiple key employees under the company's stock award plan and stock option plan, with an exercise price of HK$13.52 per share based on the closing price of the company's stock on the day of grant. The total amount of the award plan can reach HK$54.14 million.

 

The announcement stated that the company granted a total of 1,614,000 shares of bonus stock to 36 eligible participants (all of whom are employees of the group). The grant price for these bonus shares was zero, while the closing price of the company's stock on the day of grant was HK$13.52 per share.

 

Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M
Announcement Document | Image Source: Smoore International

 

The vesting period for these stock rewards is set between May 7, 2026 and May 7, 2029. The company stated that the number of shares granted to each recipient is based on their position, tenure, and performance evaluation results.

 

After this round of awards, according to the stock award plan, there are still 307,546,059 shares available for future grants.

 

In addition, on the same day, Smoore International also granted a total of 2,390,000 stock options to 13 eligible participants (all of whom are employees of the group) under the revised first public offering stock option plan.

 

Smoore Announces Equity Incentive Plan: Grants Over 4M Shares to 49 Employees, Valued at Over HK$54.14M
Notice document | Image source: Smoore International

 

The exercise price for these stock options is set at HK$13.52 per share. The options are valid for a period of 10 years from the date of issuance, expiring on May 6, 2035. The vesting period for the options is from May 7, 2026 to May 7, 2029, and the specific exercise periods for different batches of options vary, with the latest exercise date being May 6, 2035. Similar to stock awards, the number of stock options granted is tied to the individual's rank, tenure, and performance evaluation results.

 

After this equity purchase, a total of 554,727,627 shares will be available for future grants based on the authorized limit of the equity purchase plan.

 

The company emphasized that the issuance of stock awards and stock options in this round must be accepted by the recipients before they can take effect, and are subject to clawback provisions outlined in each respective plan. Specifically, if the recipients terminate their employment, any unvested stock awards and stock options will be forfeited. The company's board of directors believes that these incentive measures will help boost employee motivation and cohesion, ultimately fostering continuous growth and value creation for the company.

 

According to the listing rules, the issuance does not require approval from the company's shareholders. The company also confirms that the recipients of the issuance are not directors, senior executives, major shareholders, or their affiliates.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
According to public records from China’s National Intellectual Property Administration, a patent application filed by China Tobacco Yunnan Industrial Co., Ltd. for “cigar flavor granules” was published on May 12, 2026. The filing proposes purifying an ethanol extract of cigar tobacco leaves using LX-8 macroporous resin, followed by encapsulation with maltodextrin and sucrose fatty acid ester to improve smoking comfort, reduce dryness and enhance aroma release stability in reconstituted tobacco.
Jun.10
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
China’s e-cigarette export value declined to $694 million in April 2026, marking the lowest April level in the past three years. The data is notable because April was the first full month after China removed export VAT rebates for certain e-cigarette products. Compared with April 2025, export value fell 20.9%; compared with April 2024, it was down 22.3%. Month-on-month, exports dropped 23.2% from March 2026.
Special Report
May.23
UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
The UK Parliament’s Parliamentary Office of Science and Technology (POST) has published a scientific briefing reviewing current evidence on the health effects of vape device components, including heating elements, power settings, metals, plastics, batteries and e-liquid ingredients, signalling growing regulatory attention to device design and whole-product systems beyond e-liquids, flavours and packaging.
Special Report
Jun.29
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15